Securis Investment Partners, a leading insurance linked securities (ILS) manager, is committed to ensuring best-in-class analytics throughout the business. As part of this, the private non-life origination team wanted to understand how the latest exposure data augmentation tools and techniques could be used to enhance quality of cedants’ underlying exposure data, and what impact this could have on their risk selection and pricing strategies. “Catastrophe model output is still the common language of risk for risk transfer,” says Paul Wilson, Head of Non-Life Analytics at Securis. “ This was an opportunity to explore the value of assessing and potentially investing in augmenting the data we receive.” In 2019, Securis commissioned the RMS Consulting Team to analyze and enhance

Join for free to read